{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T12:57:49Z","timestamp":1762865869332,"version":"3.38.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Toxicology Letters"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1016\/j.toxlet.2011.10.012","type":"journal-article","created":{"date-parts":[[2011,10,24]],"date-time":"2011-10-24T16:11:02Z","timestamp":1319472662000},"page":"82-91","source":"Crossref","is-referenced-by-count":8,"title":["N-vinylpyrrolidone dimer, a novel formulation excipient, causes hepatic and thyroid hypertrophy through the induction of hepatic microsomal enzymes in rats"],"prefix":"10.1016","volume":"208","author":[{"given":"Yi","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rita","family":"Ciurlionis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth","family":"Kowalkowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kennan C.","family":"Marsh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William M.","family":"Bracken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric A.G.","family":"Blomme","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.toxlet.2011.10.012_bib0005","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.ijpharm.2006.07.014","article-title":"Exploring the potential of N-methyl pyrrolidone as a cosurfactant in the microemulsion systems","volume":"326","author":"Bachhav","year":"2006","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.toxlet.2011.10.012_bib0010","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.toxlet.2008.09.017","article-title":"Use of toxicogenomics to understand mechanisms of drug-induced hepatotoxicity during drug discovery and development","volume":"186","author":"Blomme","year":"2009","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.toxlet.2011.10.012_bib0015","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1007\/BF00599824","volume":"42","author":"Breitenbach","year":"1955","journal-title":"Naturwissenschaften"},{"key":"10.1016\/j.toxlet.2011.10.012_bib0020","unstructured":"Breitenbach, J., Heger, R., Simon, D., 2003. Test system for characterizing the compatibility of bioactive substances and polyvinylpyrrolidone. United States Patent 6,599,931 (29.07.03)."},{"key":"10.1016\/j.toxlet.2011.10.012_bib0025","series-title":"Casarett & Doull's Toxicology: The Basic Science of Poisons","first-page":"807","article-title":"Toxic response of the endocrine system","author":"Capen","year":"2008"},{"key":"10.1016\/j.toxlet.2011.10.012_bib0030","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1177\/019262338901700205","article-title":"The effects of xenobiotics on the structure and function of thyroid follicular and C-cells","volume":"17","author":"Capen","year":"1989","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.toxlet.2011.10.012_bib0035","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0140-6736(74)92906-7","article-title":"Are anticonvulsants oncogenic?","volume":"1","author":"Clemmesen","year":"1974","journal-title":"Lancet"},{"key":"10.1016\/j.toxlet.2011.10.012_bib0040","doi-asserted-by":"crossref","first-page":"8677","DOI":"10.1073\/pnas.82.24.8677","article-title":"Thyrotropin upregulates alpha 1-adrenergic receptors in rat FRTL-5 thyroid cells","volume":"82","author":"Corda","year":"1985","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.toxlet.2011.10.012_bib0045","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1210\/edrv-12-2-135","article-title":"The effect of hepatic enzyme-inducing drugs on thyroid hormones and the thyroid gland","volume":"12","author":"Curran","year":"1991","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.toxlet.2011.10.012_bib0050","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1210\/edrv-10-4-537","article-title":"The causes of autoimmune thyroid disease","volume":"10","author":"DeGroot","year":"1989","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.toxlet.2011.10.012_bib0055","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.2174\/1568026043387115","article-title":"Induction of cytochromes P450","volume":"4","author":"Dickins","year":"2004","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.toxlet.2011.10.012_bib0060","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1177\/0192623310374332","article-title":"Effects of hepatic drug-metabolizing enzyme induction on clinical pathology parameters in animals and man","volume":"38","author":"Ennulat","year":"2010","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.toxlet.2011.10.012_bib0065","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1002\/ijc.2910610506","article-title":"Is residence in areas of endemic goiter a risk factor for thyroid cancer?","volume":"61","author":"Galanti","year":"1995","journal-title":"Int. J. Cancer."},{"key":"10.1016\/j.toxlet.2011.10.012_bib0070","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1289\/ehp.7690","article-title":"Molecular characterization of thyroid toxicity: anchoring gene expression profiles to biochemical and pathologic end points","volume":"113","author":"Glatt","year":"2005","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.toxlet.2011.10.012_bib0075","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0026-895X(24)12603-X","article-title":"Regulation of the human CYP2B6 gene by the nuclear pregnane X receptor","volume":"60","author":"Goodwin","year":"2001","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.toxlet.2011.10.012_bib0080","unstructured":"2002. Guiding principles in the use of animals in toxicology. Adopted by the Society of Toxicology in July 1989. Toxicol. Appl. Pharmacol. 178, 4."},{"key":"10.1016\/j.toxlet.2011.10.012_bib0085","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1080\/00498250701534893","article-title":"Induction of hepatic cytochrome P450 enzymes: methods, mechanisms, recommendations, and in vitro-in vivo correlations","volume":"37","author":"Hewitt","year":"2007","journal-title":"Xenobiotica"},{"key":"10.1016\/j.toxlet.2011.10.012_bib0090","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1289\/ehp.98106447","article-title":"Risk assessment of thyroid follicular cell tumors","volume":"106","author":"Hill","year":"1998","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.toxlet.2011.10.012_bib0095","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1006\/taap.1999.8752","article-title":"Effects of microsomal enzyme inducers on thyroid-follicular cell proliferation, hyperplasia, and hypertrophy","volume":"160","author":"Hood","year":"1999","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.toxlet.2011.10.012_bib0100","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1093\/toxsci\/50.1.45","article-title":"Effects of phenobarbital, pregnenolone-16alpha-carbonitrile, and propylthiouracil on thyroid follicular cell proliferation","volume":"50","author":"Hood","year":"1999","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.toxlet.2011.10.012_bib0105","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/toxsci\/49.2.263","article-title":"Sensitivity of thyroid gland growth to thyroid stimulating hormone (TSH) in rats treated with antithyroid drugs","volume":"49","author":"Hood","year":"1999","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.toxlet.2011.10.012_bib0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2007.03.056","article-title":"Solubilization of poorly soluble compounds using 2-pyrrolidone","volume":"342","author":"Jain","year":"2007","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.toxlet.2011.10.012_bib0115","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1007\/BF01974069","article-title":"Assessment of the influence of subacute phenobarbitone administration on multi-tissue cell proliferation in the rat using bromodeoxyuridine immunocytochemistry","volume":"67","author":"Jones","year":"1993","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.toxlet.2011.10.012_bib0120","doi-asserted-by":"crossref","first-page":"6318","DOI":"10.1128\/MCB.19.9.6318","article-title":"Phenobarbital-responsive nuclear translocation of the receptor CAR in induction of the CYP2B gene","volume":"19","author":"Kawamoto","year":"1999","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.toxlet.2011.10.012_bib0125","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1124\/mol.62.3.638","article-title":"Nuclear pregnane x receptor and constitutive androstane receptor regulate overlapping but distinct sets of genes involved in xenobiotic detoxification","volume":"62","author":"Maglich","year":"2002","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.toxlet.2011.10.012_bib0130","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1177\/0192623310373778","article-title":"Hepatic enzyme induction: histopathology","volume":"38","author":"Maronpot","year":"2010","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.toxlet.2011.10.012_bib0135","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/0041-008X(89)90004-5","article-title":"The effect of phenobarbital on the metabolism and excretion of thyroxine in rats","volume":"99","author":"McClain","year":"1989","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.toxlet.2011.10.012_bib0140","doi-asserted-by":"crossref","first-page":"15122","DOI":"10.1074\/jbc.M001215200","article-title":"Orphan nuclear receptors constitutive androstane receptor and pregnane X receptor share xenobiotic and steroid ligands","volume":"275","author":"Moore","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.toxlet.2011.10.012_bib0145","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0006-2952(99)00310-X","article-title":"Role of the aromatic hydrocarbon receptor and [Ah] gene battery in the oxidative stress response, cell cycle control, and apoptosis","volume":"59","author":"Nebert","year":"2000","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.toxlet.2011.10.012_bib0150","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1093\/jnci\/81.10.803","article-title":"Cancer among epileptic patients exposed to anticonvulsant drugs","volume":"81","author":"Olsen","year":"1989","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.toxlet.2011.10.012_bib0155","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1101\/gad.14.15.1837","article-title":"Wnt signaling and cancer","volume":"14","author":"Polakis","year":"2000","journal-title":"Genes Dev."},{"key":"10.1016\/j.toxlet.2011.10.012_bib0160","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1210\/en.2004-1350","article-title":"Role of the constitutive androstane receptor in xenobiotic-induced thyroid hormone metabolism","volume":"146","author":"Qatanani","year":"2005","journal-title":"Endocrinology"},{"key":"10.1016\/j.toxlet.2011.10.012_bib0165","first-page":"348","article-title":"The syndromes of resistance to thyroid hormone","volume":"14","author":"Refetoff","year":"1993","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.toxlet.2011.10.012_bib0170","first-page":"6105","article-title":"Overexpression and overactivation of Akt in thyroid carcinoma","volume":"61","author":"Ringel","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.toxlet.2011.10.012_bib0175","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.mce.2009.10.016","article-title":"The PI3K-Akt-mTOR pathway in initiation and progression of thyroid tumors","volume":"321","author":"Saji","year":"2010","journal-title":"Mol. Cell Endocrinol."},{"key":"10.1016\/j.toxlet.2011.10.012_bib0180","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0041-008X(89)90231-7","article-title":"The effects of chronic ingestion of spironolactone on serum thyrotropin and thyroid hormones in the male rat","volume":"98","author":"Semler","year":"1989","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.toxlet.2011.10.012_bib0185","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0303-7207(87)90118-3","article-title":"In vitro demonstration of a TSH-specific growth desensitising mechanism in rat thyroid epithelium","volume":"51","author":"Smith","year":"1987","journal-title":"Mol. Cell Endocrinol."},{"key":"10.1016\/j.toxlet.2011.10.012_bib0190","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1177\/019262339101900301","article-title":"Studies on the mechanism of simvastatin-induced thyroid hypertrophy and follicular cell adenoma in the rat","volume":"19","author":"Smith","year":"1991","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.toxlet.2011.10.012_bib0195","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1210\/endo-116-2-611","article-title":"In vitro evidence for an intracellular mechanism limiting the thyroid follicular cell growth response to thyrotropin","volume":"116","author":"Stringer","year":"1985","journal-title":"Endocrinology"},{"key":"10.1016\/j.toxlet.2011.10.012_bib0200","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1124\/jpet.107.126938","article-title":"Gene expression analysis in rats treated with experimental acetyl-coenzyme A carboxylase inhibitors suggests interactions with the peroxisome proliferator-activated receptor alpha pathway","volume":"324","author":"Waring","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.toxlet.2011.10.012_bib0205","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1093\/bioinformatics\/btl045","article-title":"Rosetta error model for gene expression analysis","volume":"22","author":"Weng","year":"2006","journal-title":"Bioinformatics"},{"key":"10.1016\/j.toxlet.2011.10.012_bib0210","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/01.mjt.0000209673.01885.b0","article-title":"Preclinical development of new drugs that enhance thyroid hormone metabolism and clearance: inadequacy of using rats as an animal model for predicting human risks in an IND and NDA","volume":"13","author":"Wu","year":"2006","journal-title":"Am. J. Ther."},{"key":"10.1016\/j.toxlet.2011.10.012_bib0215","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1530\/acta.0.1010210","article-title":"Dissociation of growth and function in the rat thyroid during prolonged goitrogen administration","volume":"101","author":"Wynford-Thomas","year":"1982","journal-title":"Acta Endocrinol. (Copenh)"},{"key":"10.1016\/j.toxlet.2011.10.012_bib0220","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1158\/1535-7163.MCT-05-0078","article-title":"Integrin-linked kinase is a potential therapeutic target for anaplastic thyroid cancer","volume":"4","author":"Younes","year":"2005","journal-title":"Mol. Cancer. Ther."},{"key":"10.1016\/j.toxlet.2011.10.012_bib0225","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1177\/0192623311406934","article-title":"Characterization of xenobiotic-induced hepatocellular enzyme induction in rats: anticipated thyroid effects and unique pituitary gland findings","volume":"39","author":"Zabka","year":"2011","journal-title":"Toxicol. Pathol."}],"container-title":["Toxicology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378427411015797?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378427411015797?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T06:56:45Z","timestamp":1741849005000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378427411015797"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S0378427411015797"],"URL":"https:\/\/doi.org\/10.1016\/j.toxlet.2011.10.012","relation":{},"ISSN":["0378-4274"],"issn-type":[{"type":"print","value":"0378-4274"}],"subject":[],"published":{"date-parts":[[2012,1]]}}}